Skip to content
10-Q

Quarterly Report

HILLEVAX, INC.

0000950170-24-094276

← back to feed
Filed
Aug 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 5, 2024 49.78M sh
Short Term Debt Q2 2024 · Jun 30, 2024 $25.67M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $108.44M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $216.68M
Current Liabilities Q2 2024 · Jun 30, 2024 $49.17M
Current Liabilities Q2 2024 · Dec 31, 2023 $29.27M
Total Liabilities Q2 2024 · Jun 30, 2024 $72M
Total Liabilities Q2 2024 · Dec 31, 2023 $78.91M
Current Assets Q2 2024 · Jun 30, 2024 $252.53M
Current Assets Q2 2024 · Dec 31, 2023 $310.68M
Total Assets Q2 2024 · Jun 30, 2024 $276.93M
Total Assets Q2 2024 · Dec 31, 2023 $344.43M
Long Term Debt Q2 2024 · Dec 31, 2023 $25.24M
Shares Diluted Q2 2024 · Jun 30, 2023 37.95M sh
Shares Diluted Q2 2024 · Jun 30, 2023 37.85M sh
Capex Q2 2024 · Jun 30, 2023 $7.82M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$38.37M
Stockholders Equity Q2 2024 · Jun 30, 2023 $218.76M
Stockholders Equity Q2 2024 · Mar 31, 2023 $243.06M
Stockholders Equity Q2 2024 · Dec 31, 2022 $267.23M
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.74
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.45
Eps Basic Q2 2024 · Jun 30, 2023 −$0.74
Eps Basic Q2 2024 · Jun 30, 2023 −$1.45
Sga Expense Q2 2024 · Jun 30, 2023 $7.23M
Sga Expense Q2 2024 · Jun 30, 2023 $13.03M
Net Income Q2 2024 · Jun 30, 2023 −$27.9M
Net Income Q2 2024 · Jun 30, 2023 −$54.79M
Operating Income Q2 2024 · Jun 30, 2023 −$30.18M
Operating Income Q2 2024 · Jun 30, 2023 −$59.14M